IRMD
Iradimed·NASDAQ
--
--(--)
--
--(--)
IRMD fundamentals
Iradimed (IRMD) Revenue Breakdown: Q3 2025 Business & Regional Performance
Iradimed (IRMD) reported total revenue of 21.20M USD in Q3 2025, with its core business segment Devices contributing 73.50%. Regionally, United States remained the largest market, accounting for 85.44% of total revenue. Explore Iradimed's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Iradimed (IRMD) reported total revenue of 21.20M USD in Q3 2025, with its core business segment Devices contributing 73.50%. Regionally, United States remained the largest market, accounting for 85.44% of total revenue. Explore Iradimed's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What factors drove the changes in Iradimed's revenue and profit?What is Iradimed's latest dividend and current dividend yield?Did Iradimed beat or miss consensus estimates last quarter?What were the key takeaways from Iradimed’s earnings call?What is the revenue and EPS growth rate for Iradimed year over year?What were the key takeaways from Iradimed's earnings call?What guidance did Iradimed's management provide for the next earnings period?What does Iradimed do and what are its main business segments?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
